Community Occupational Therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID]) study: A single-blind, randomised controlled trial
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Community Occupational Therapy in Dementia-UK version (COTiD-UK) did not improve daily living activities for people with dementia or family carer competence compared to usual care. Future research should focus on person-centered outcomes like goal achievement.
Area Of Science
- Gerontology
- Rehabilitation Medicine
- Neuroscience
Background
- Dementia care presents challenges for individuals and family caregivers.
- Community-based occupational therapy aims to support daily living activities and caregiver well-being.
Purpose Of The Study
- To evaluate the clinical effectiveness of the Community Occupational Therapy in Dementia-UK version (COTiD-UK) intervention.
- To compare COTiD-UK against treatment as usual (TAU) for people with dementia and their family carers.
Main Methods
- A multicentre, randomised controlled trial (RCT) involving 468 pairs of people with dementia and family carers.
- Intervention group received 10 hours of COTiD-UK over 10 weeks; control group received TAU.
- Primary outcome: Bristol Activities of Daily Living Scale (BADLS) at 26 weeks.
Main Results
- No significant difference in BADLS scores between COTiD-UK and TAU groups at 26 weeks (p=0.55).
- Secondary outcomes, including cognition, quality of life, mood, and carer competence, also showed no significant differences.
- 91% of activity-based goals set within the COTiD-UK intervention were achieved.
Conclusions
- Community occupational therapy, as delivered, did not enhance daily living activities or caregiver competence in dementia.
- Future research should prioritize person-centered outcomes, such as goal attainment and activity engagement, for more meaningful evaluation.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
• Purpose: Documentation in long-term care facilities is critical for interprofessional resident assessment and planning. It ensures that all aspects of a resident's care - from medical needs to daily living assistance - are thoroughly...
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...